New Delhi, June 11: Morepen Labs has filed a patent application for a new process to manufacture Montelukast Sodium, a drug for asthma and pediatric use. The international process patent application is for the preparation of Montelukast acid and sodium salt thereof, a company release said here on Tuesday.
The antiasthamatic drug prescribed as single dose with an added advantage of pediatric use has an estimated market of $1.24 billion with a 24 per cent growth rate in the US, it said. Bureau Report